LOTTE Biologics (롯데바이오로직스)

Welcome to the official YouTube channel of LOTTE Biologics.

Founded in 2022 and headquartered in Seoul, Korea, LOTTE Biologics is a next-generation CDMO dedicated to delivering therapies that contribute to a healthier world.

At our Syracuse Bio Campus in New York, we offer GMP drug substance manufacturing with 40,000L total capacity, advanced QC labs, and over 60 global regulatory approvals. We are also expanding into ADC services with over $100 million invested in on-site drug substance and conjugation capabilities.

In Songdo, Korea, we are building three state-of-the-art bio plants, with the first set to begin operations in 2027. Once complete, the facilities will provide over 360,000L of bioreactor capacity for both clinical and commercial supply.

Subscribe to see how LOTTE Biologics is shaping the future of global biomanufacturing.